Spero Therapeutics, Inc. is in its Ketu mahadasha (8 Oct 2025 to 8 Oct 2032), Venus antardasha (6 Mar 2026 to 6 May 2027) and Jupiter pratyantar (9 Oct 2026 to 5 Dec 2026).
Next: pratyantar Saturn from 5 Dec 2026; antardasha Sun from 6 May 2027; mahadasha Venus from 8 Oct 2032.
| Planet | Sign | Degree | House | Nakshatra |
|---|---|---|---|---|
| Sun | Tula (Libra) | 16°14′ | 12th | Swati 3 |
| Moon | Meena (Pisces) | 23°47′ | 5th | Revati 3 |
| Mars | Kanya (Virgo) | 12°44′ | 11th | Hasta 1 |
| Mercury | Vrishchika (Scorpio) | 1°09′ | 1st | Vishakha 4 |
| Jupiter | Tula (Libra) | 10°55′ | 12th | Swati 2 |
| Venus | Kanya (Virgo) | 29°46′ | 11th | Chitra 2 |
| Saturn | Dhanu (Sagittarius) | 0°41′ | 2nd | Mula 1 |
| Rahu | Karka (Cancer) | 25°58′ | 9th | Ashlesha 3 |
| Ketu | Makara (Capricorn) | 25°58′ | 3rd | Dhanishta 1 |
Whole-sign houses counted from the lagna, True Chitra ayanamsa, Vimshottari dashas from the Moon's nakshatra. How the chart is cast.
The full chart adds the D1, D9 and D10 charts to explore, every antardasha and pratyantar, how SPRO moved in each period against the S&P 500, transits, fundamentals and news.